Navigation Links
Lexicon Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
Date:5/31/2011

THE WOODLANDS, Texas, May 31, 2011 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that Arthur T. Sands, M.D., Ph.D., Lexicon's president and chief executive officer, will present at the Jefferies 2011 Global Healthcare Conference on Wednesday, June 8, 2011 at 10:30 a.m. Eastern Time in New York City.  Dr. Sands will provide an overview on Lexicon's clinical development programs and milestones.

The Jefferies Global Healthcare Conference will feature informative presentations from more than 300 leading public and private healthcare companies across the healthcare services, life sciences, medical technology, healthcare IT, and biopharmaceuticals sectors.

A live webcast of the event may be accessed on Lexicon's corporate website at www.lexpharma.com.  An archived version of the webcast will be available for 30 days after the event on the company's website.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has four drug candidates in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Lexicon Pharmaceuticals to Present at the 10th Annual Needham Healthcare Conference
2. Lexicon Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference
3. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results
4. Lexicon to Present at Stifel Nicolaus Healthcare Conference
5. Lexicon to Present at Morgan Stanley Global Healthcare Conference
6. Lexicon to Present at Two Major Healthcare Investor Conferences
7. Lexicon Announces Pricing of Common Stock in Public Offering
8. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Fourth Quarter and Full Year Financial Results
9. Lexicon Announces Proposed Offering of 27,500,000 Shares of Common Stock
10. Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
11. Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on July 28, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/27/2014)... 2014 Kalorama Information says that PCR is ... the United States and is ... researcher said the FDA,s Emergency Use Authorization (EUA) to authorize ... the detection of the Ebola virus was an indication ... assess the IVD industry and its biennial survey on ...
(Date:10/27/2014)... The report “Smart Highway Market ... Communication, Monitoring), and by Display (Variable Message Signs, ... the global market into various sub-segments with in-depth ... the drivers and restraints for this market with ... 75 market tables and 37 figures spread through ...
(Date:10/26/2014)... The report "Data Center Networking ... Equipment, WAN Optimization Appliances]: Global Advancements, Worldwide Forecasts ... center networking market into various segments with an ... also identifies the factors driving this market, various ... with the future roadmaps. , Browse 106 market ...
(Date:10/25/2014)... (PRWEB) October 23, 2014 BioProcess ... winners for the 2014 BioProcess International Awards. The ... social corporate responsibility and technology applications that will ... treatments to a global patient base. , Winners ... peers during a very entertaining and exciting awards ...
Breaking Biology Technology:Kalorama: PCR The Go-to Test in Ebola Fight 2Kalorama: PCR The Go-to Test in Ebola Fight 3Smart Highway Market by Technology, and Display Expected to Reach $27.992.0 Million by 2019- New Report by MarketsandMarkets 2Smart Highway Market by Technology, and Display Expected to Reach $27.992.0 Million by 2019- New Report by MarketsandMarkets 3Smart Highway Market by Technology, and Display Expected to Reach $27.992.0 Million by 2019- New Report by MarketsandMarkets 4Data Center Networking Market by Ethernet Switches, SAN & Routers Worth $21.85 Billion by 2018 - New Report by MarketsandMarkets 2Data Center Networking Market by Ethernet Switches, SAN & Routers Worth $21.85 Billion by 2018 - New Report by MarketsandMarkets 3Data Center Networking Market by Ethernet Switches, SAN & Routers Worth $21.85 Billion by 2018 - New Report by MarketsandMarkets 4BioProcess International Announces Winners of the 2014 BioProcess International Awards 2BioProcess International Announces Winners of the 2014 BioProcess International Awards 3BioProcess International Announces Winners of the 2014 BioProcess International Awards 4BioProcess International Announces Winners of the 2014 BioProcess International Awards 5
... BEIJING, Aug. 20 /PRNewswire-Asia-FirstCall/ -- China Medical ... leading China-based medical device,company that develops, manufactures and markets ... its unaudited financial results,for the fourth fiscal quarter ("4Q ... the first fiscal quarter ("1Q FY2009") ended June 30, ...
... , SEATTLE, Aug. 19 Cell Therapeutics, Inc. ... into an agreement to sell $30 million of shares of its Series ... in a registered offering to a single institutional investor. Each share ... holder, at any time during its existence, into approximately 628 shares of ...
... , , COLUMBIA, Md., Aug. 19 Martek Biosciences ... the results of its third quarter of fiscal 2009 on September 2, ... at 4:45 p.m. ET Martek will conduct a conference call to discuss ... call live via webcast by visiting Martek,s web site at ...
Cached Biology Technology:China Medical Technologies to Announce Unaudited Financial Results for the Fourth Fiscal Quarter and Fiscal Year ended March 31, 2009 and the First Fiscal Quarter ended June 30, 2009 on September 1, 2009 2Cell Therapeutics, Inc. Announces Institutional Investor Purchases $30 Million of Preferred Stock and Warrants 2Cell Therapeutics, Inc. Announces Institutional Investor Purchases $30 Million of Preferred Stock and Warrants 3
(Date:10/29/2014)... by the international Cancer Genomics of the Kidney ... between kidney cancer and exposure to aristolochic acid, ... published in Nature Communications , have important ... more than 140,000 people every year, and in ... CAGEKID, part of the International Cancer Genome Consortium ...
(Date:10/28/2014)... have published a paper in the Proceedings of ... details about key transitions in the evolution of plant ... mosses, ferns, trees and flowers growing deep in steamy ... the ornamental plants adorning our homes, all plant life ... "Our study generated DNA sequences from a vast number ...
(Date:10/28/2014)... be building a hybrid micro-grid which will integrate ... in the region, the hybrid micro-grid will test ... diesel, storage and power-to-gas technologies, and ensure these ... built under the new Renewable Energy Integration Demonstrator- ... located offshore at Semakau Landfill and is expected ...
Breaking Biology News(10 mins):Kidney cancer in Central Europe 2New study uses DNA sequences to look back in time at key events in plant evolution 2New study uses DNA sequences to look back in time at key events in plant evolution 3NTU to build region's first renewable energy integration demonstration micro-grid 2NTU to build region's first renewable energy integration demonstration micro-grid 3
... Mary Lee Dequeant, Ph.D., a Predoctoral Researcher at the ... Stowers Institute Investigator and an investigator with the Howard ... respectively, on a paper that identifies a network of ... of spine formation in the embryo. , ...
... identified the molecular signature of these epidermal neural crest ... conflicting scientific opinions by showing that these cells are ... Their work provides a valuable resource for future mouse ... the research from Dr. Maya Sieber-Blum's laboratory, co-authored by ...
... University researchers have identified a unique mechanism of action ... the treatment of multiple sclerosis. , The researchers report ... drug that was already known to affect the functioning ... white blood cells from the lymph nodes into the ...
Cached Biology News:Stem cells found in adult hair follicles may provide alternative to embryonic stem cells 2Novel mechanism of action of new drug for MS identified 2
... (100+kb), fosmid (40kb), and large plasmid insert ... othe BAC vector. On command 20-50 fold ... recombinant DNA purification. Available with blue-white screening ... for the highest insert stability. Kits include ...
... System is used in conjunction ... PCR of problematic and/or GC-rich ... Solution with 10X PCRX Amplification ... broader magnesium concentration broader annealing ...
6-carboxy-2',4,4',5',7,7'-hexachlorofluorescein, succinimidyl ester (6-HEX, SE) *single isomer*...
Mouse Exodus 2 - 12kDa...
Biology Products: